WednesdayDec 08, 2021 2:55 pm

QualityStocksNewsBreaks – Sharing Services Global Corporation (SHRG) Subsidiary Poised as Recognized Leader in Natural Nootropics

Sharing Services Global’s (OTCQB: SHRG) subsidiary the Happy Co., a direct-sales opportunity that offers functional beverages, capsules, patches and creams featuring nootropics, could witness significant benefit from the projected growth in the global nootropics market. A recent report projects that this space, which reached $2.42 billion in 2020, will top $6.29 billion by 2028, growing at a CAGR of 12.71% during the forecast period (https://ibn.fm/liOgS). The report attributes the growth to the rise in demand for cognitive enhancers or smart drugs among the global population to enhance memory and stay focused. “One of the fastest-growing companies in the social-marketing and…

Continue Reading

WednesdayDec 08, 2021 2:46 pm

QualityStocksNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) Delivering Evidence-Based DTx, Research Centered Around Psychedelics

Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) (“MINDCURE”), a leader in advanced proprietary technology and research for psychedelics, recently released an operational update regarding the strategic initiatives of its operating segments – MINDCURE Research and MINDCURE Technology. The update detailed the company’s progress and plans for the immediate future. “As a member of the Digital Therapeutics Alliance, MINDCURE delivers digital therapeutics (‘DTx’) that are evidence-based interventions driven by high-quality software to prevent, manage and treat medical disorders,” reads a recent article. A leader in advanced proprietary technology and research centered around psychedelics, MINDCURE is currently advancing multiple programs and products…

Continue Reading

WednesdayDec 08, 2021 2:36 pm

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Clinical Trials, Focus Puts It ‘In Pretty Rarefied Air’

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) is advancing toward the launch of four phase 2a studies of its two novel drug candidates, TRP-8802 and TRP-8803, for treating fibromyalgia, phantom limb pain, complex regional pain syndrome (“CRPS”) and select eating disorders. Tryp filed an IND with the U.S. Food and Drug Administration in September for treating overeating disorders in Florida and filed its second IND application earlier in November for fibromyalgia testing in Michigan. The FDA asked the company to change the scope of its eating disorders trial so that the initial Florida investigation can focus on patients with binge eating…

Continue Reading

WednesdayDec 08, 2021 1:58 pm

QualityStocksNewsBreaks – Sugarmade Inc. (SGMD) Releases Corporate Update, Notes Nug Avenue Growth

Sugarmade (OTC: SGMD), an emerging leader in the vertically integrated cannabis marketplace based in California, is moving toward new growth initiatives and expanding organically, according to a recent corporate update. The company noted that the expansion was organic, within the framework of its primary operating vision. Currently, Sugarmade operates a Nug Avenue location in Los Angeles, which has seen significant growth since opening its doors in March of this year. Within only three months, the location reported 10,000 unique members, and that impressive growth has continued, with the company most recently reporting 25,000 unique members. Sugarmade is planning to open…

Continue Reading

WednesdayDec 08, 2021 1:29 pm

QualityStocksNewsBreaks – Asia Broadband Inc. (AABB) Announces Scheduled December Launch of Proprietary Cryptocurrency Exchange

Asia Broadband (OTC: AABB) today announced a confirmed release date of Dec. 28, 2021, for its proprietary cryptocurrency exchange (the “Exchange”) within the AABB Wallet. In collaboration with AABB’s digital assets developer, the integration and testing of network components continues in preparation for the initial staged launch of the Exchange. Currently, 150 cryptocurrency Exchange trading pairs have been added into to the BCGateway platform, while 50 more will be added in the coming weeks. The Exchange project has evolved in recent months to vastly improve the finished product. This includes the addition of many new features and capabilities to expand…

Continue Reading

WednesdayDec 08, 2021 1:11 pm

QualityStocksNewsBreaks – PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) Launches PlantX Shop to Complement, Expand E-Commerce Capabilities

PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) today announced the launch of PlantX Shop, the company’s new mobile application designed to enhance customer engagement and satisfaction by enabling a faster, simpler and more interactive shopping experience. The app, which aims to complement and expand the company’s existing e-commerce capabilities, will be available to all PlantX customers on iOS and Android mobile devices in Canada and the United States. “The new PlantX app offers us a truly exciting advantage in interacting with our community in more efficient and dynamic ways,” said PlantX CEO Lorne Rapkin. “There are many research studies…

Continue Reading

WednesdayDec 08, 2021 12:52 pm

QualityStocksNewsBreaks – Tingo Inc. (IWBB), Data Vault Holdings Inc. Collaborate to Deliver Data Revenue to 10M Users Throughout Nigeria

Data Vault Holdings, leading the way in tokenomics and metaverse data visualization, valuation and monetization, today announced that 10 million users will be added to the Datavault(R) platform via its partnership with Tingo (OTC: IWBB), a leading agri-fintech business in Africa that has delivered significant impact with its unique rural communities-based business model. Per the update, the groundbreaking deal will provide 10 million users throughout Nigeria economic autonomy via data monetization with the cryptocurrency exchange CoinField. The deal represents a keystone partnership helping to build a data-backed cryptocurrency that will unleash the true economic power within Tingo's user base. “I…

Continue Reading

WednesdayDec 08, 2021 12:06 pm

QualityStocksNewsBreaks – InnerScope Hearing Technologies Inc. (INND) Announces Walmart POs for More than $277,000 In-Store Product Sales

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer (“DTC”) hearing technology space, announced that HearingAssist, its wholly owned subsidiary, has received orders from Walmart for more than $277,000 worth of its EZ-Hear Neckband Bluetooth Hearing Amplifier. According to the announcement, the devices will be displayed in more than 750 Walmart stores located throughout Texas, North Carolina, Tennessee, Colorado and Arizona. HearingAssist is Walmart's largest direct-ship and wholesale hearing aid supplier. HearingAssist is ramping up product of the hearing amplifiers to fill the orders and is also rolling out hearing-aid product displays; the company anticipates receiving additional…

Continue Reading

WednesdayDec 08, 2021 11:53 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Follow-Up Study Results Confirming DehydraTECH(TM)-CBD Arterial Stiffness Reduction

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, is reporting additional results from its human clinical study HYPER-H21-2. The study was designed to evaluate the company’s proprietary DehydraTECH(TM)-processed cannabidiol ("CBD") and its effectiveness in the treatment of hypertension. Results confirm the substance’s ability to reduce arterial stiffness and indicate potential broader applications beyond hypertension, including the treatment of cardiovascular and other diseases. According to the company, arterial stiffness can be a predictor of a variety of human diseases, including hypertension, diabetes mellitus, renal disease and more. A unique CBD formulation developed by Lexaria, DehydraTECH-CBD is based on the…

Continue Reading

WednesdayDec 08, 2021 11:37 am

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Moving Rapidly to Progress CYB003 Toward Clinical Development

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” has announced a confirmed scientific advice meeting with the UK Medical and Healthcare Products Regulatory Agency (“MHRA”) for the first quarter of calendar year 2022. According to the update, this program milestone brings Cybin closer to advancing its lead investigational candidate CYB003 into clinical development for the treatment of major depressive disorder (“MDD”) and alcohol use disorder (“AUD”). “Encouraged by positive preclinical findings that demonstrated the advantages of our novel deuterated psilocybin analog over oral psilocybin for the treatment of mental health, we are moving…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered